Humoral Response to Third Dose of SARS-CoV-2 Vaccines in the CKD Spectrum

Anti-Spike antibodies during follow-up in CKD cohorts. (A) Anti-Spike antibodies titers during follow-up in different CKD cohorts. Data show anti-Spike antibodies titers of all patients irrespective of their baseline anti-Spike antibody titers. (B) Presence of anti-Spike antibodies during follow-up in the different CKD cohorts. Data are expressed as the percentage of patients with the presence of anti-Spike antibodies (i.e., titer >36 IU/ml). The table shows the sample size of each CKD group across each time point. Only significant P values are shown. HD, hemodialysis; PD, peritoneal dialysis.